ELFABRIO Chiesi Australia Pty Ltd
Product name
ELFABRIO
Sponsor
Accepted date
May-2024
Active ingredients
pegunigalsidase alfa
Proposed indication
Long-term enzyme replacement therapy.
Application type
A (new medicine)
Publication date
May-2024